Is there a role for Ethics Committees in Pre-approval Access?
In discussions with our clients over recent months...
Read More
Inceptua Q&A: What is Pre-Approval Access?
“What is pre-approval and unlicensed access to medicines?”...
Read More
Pre-approval Access
Regulatory Update 2020 The regulations governing pre-approval access...
Read More
Maintaining access to your medicines during COVID19
As an agile, global, and robust provider of...
Read More
Industry Trends in Pre-approval Access to Medicines
Expanded Access as a Key Component in the...
Read More
The 21st Century Cures Act: Turn your obligations into an advantage
The 21st Century Cures Act (21CCA), which came...
Read More
Expediting Access to Rare Disease Therapies in Europe
“Exploring Multi-Stakeholder Approaches” Globally there are approximately 7,000...
Read More
Providing Access to Unlicensed Medicines
“The Role of Pharmaceutical Manufacturers” What’s driving demand...
Read More
What life science companies need to know about pre-approval access
Pre-approval access is evolving at a rapid pace....
Read More